NCT00866515View on ClinicalTrials.gov

Drug Interaction Study to Investigate Co-administration of GW642444M With Ketoconazole

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 22, 2008

Primary Completion Date

March 27, 2009

Study Completion Date

March 27, 2009

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Ketoconazole + GW642444M

Ketoconazole 400mg OD days 1-6, GW642444M 25ug single dose on D5

DRUG

Placebo + GW642444M

Placebo to match D1-6 + GW642444M 25ug single dose on D5

Trial Locations (1)

2031

GSK Investigational Site, Randwick

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY